How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Problem solving is the mental process of analyzing a situation, learning what options are available, and then choosing the alternative that will result in the desired outcome or some other selected ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Men may be more likely to experience certain health conditions, including prostate cancer, erectile dysfunction, heart disease, lung cancer, depression, and alcohol use disorder. Early screening for ...